CDKN2A (Cyclin-Dependent Kinase Inhibitor 2A): CDKN2A is a tumour suppressor gene that produces two proteins, p16INK4A and p14ARF, which are involved in regulating the cell cycle and preventing tumour development. Mutations in CDKN2A are linked to a higher risk of several cancers, including melanoma and pancreatic cancer.